Trial Profile
Primary Vaccination Course With the Pneumococcal Vaccine GSK 1024850A, in Healthy Infants in Vietnam When Co-administered With GSK Biologicals' Infanrix Hexa (DTPa-HBV-IPV/Hib) Vaccine
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Pneumococcal 10-valent vaccine conjugate (Primary) ; Hib DTaP hepatitis B poliovirus vaccine (Infanrix hexa)
- Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Pneumococcal infections; Poliomyelitis; Tetanus
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; GSK
- 04 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 16 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.